Peptide mimics elicit antibody responses against the outer-membrane lipooligosaccharide of group B Neisseria meningitidis

FEMS Microbiology Letters

Volumn 191, Issue 1, 2000, Pages 45-50

  Charalambous, Bambos M ^a   Feavers, Ian M ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Heptapeptide phage display; Lipooligosaccharide; Neisseria meningitidis; Peptide mimic; Resonant mirror biosensor; Serogroup B; Vaccine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DIPHTHERIA TOXOID; HEPTAPEPTIDE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN SUBCLASS; MENINGOCOCCUS VACCINE; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL OUTER MEMBRANE; BINDING KINETICS; COLIPHAGE; CONTROLLED STUDY; CROSS REACTION; DRUG CONJUGATION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

EID: 0034307853     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00368-2     Document Type: Article

References (29)

1. Peltola H. Meningococcal disease: still with us. Rev. Infect. Dis. 5:1983;71-91.
2. Hart C.A., Rogers T.R.F. Meningococcal disease. J. Med. Microbiol. 39:1993;3-25.
3. Jones, D.M. (1995) Epidemiology of meningococcal disease in Europe and the USA. In: Meningococcal Disease (Cartwright, K.A.V., Ed.), pp. 147-157. John Wiley and Sons, Chichester.
4. Finne J., Leinonen M., Makela P.H. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet. ii:1983;355-357.
5. Hayrinen J., Jennings H., Raff H.V., Rougon G., Hanai N., Gerardy-Schahn R., Finne J. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1995;1481-1490.
6. Weisgerber C., Husmann M., Frosch M., Rheinheimer C., Peuckert W., Görgen I., Bitter-Suermann D. Embryonic neural cell adhesion molecule in cerebrospinal fluid of younger children: age-dependent decrease during the first year. J. Neurochem. 55:1990;2063-2071.
7. Zollinger, W.D. (1997) New and improved vaccines against meningococcal disease. In: New Generation Vaccines (Levine, M.M. et al., Eds.), pp. 469-488. Marcel Dekker, New York.
8. Jones D.M., Borrow R., Fox A.J., Gray S., Cartwright K.A., Poolman J.T. The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb. Pathogen. 13:1992;219-224.
9. Verheul A.F.M., Snippe H., Poolman J.T. Meningococcal lipopolysaccharides: Virulence factor and potential vaccine component. Microbiol. Rev. 57:1993;34-45.
10. Estabrook M.M., Griffiss J.M., Jarvis G.A. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect. Immun. 65:1997;4436-4444.
11. Estabrook M., Baker C.J., Griffiss J.M. The immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed towards primarily against two monoclonal antibody-defined epitopes. J. Infect. Dis. 167:1993;966-970.
12. Griffiss J.M., Brandt B.L., Broud D.D., Goroff D.K., Baker C.J. Immune response of infants and children to disseminated infections with Neisseria meningitidis. J. Infect. Dis. 150:1984;71-79.
13. Jennings H.J., Johnson K.G. The structure of an R-type oligosaccharide core obtained from some lipooligosaccharides of Neisseria meningiditis. Carbohydr. Res. 121:1983;233-241.
14. Verheul A.F., Kuipers A.J., Braat A.K., Dekker H.A., Peeters C.C., Snippe H., Poolman J.T. Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies. Clin. Diagn. Lab. Immunol. 1:1994;729-736.
15. Westerink M.A., Campagnari A.A., Wirth M.A., Apicella M.A. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect. Immun. 56:1988;1120-1127.
16. Grothaus M.C., Srivastava N., Smithson S.L., Kieber-Emmons T., Williams D.B., Carlone G.M., Westerink M.A. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library. Vaccine. 18:2000;1253-1263.
17. Phalipon A., Folgori A., Arondel J., Sgaramella G., Fortugno P., Cortese R., Sansonetti P.J., Felici F. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur. J. Immunol. 27:1997;2620-2625.
18. Valadon P., Nussbaum G., Oh J., Scharff M.D. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. J. Immunol. 161:1998;1829-1836.
19. Charalambous B.M., Evans J., Feavers I.M., Maiden M.C. Comparative analysis of two meningococcal immunotyping monoclonal antibodies by resonant mirror biosensor and antibody gene sequencing. Clin. Diagn. Lab. Immunol. 6:1999;838-843.
20. Messing J. New M13 vectors for cloning. Methods Enzymol. 101:1983;20-78.
21. Evans J.S., Maiden M.C.J. Purification of meningococcal lipo-oligosaccharide by FPLC techniques. Microbiology. 142:1996;57-62.
22. Lasonder E., Schellekens G.A., Koedijk D.G., Damhof R.A., Welling-Wester S., Feijlbrief M., Scheffer A.J., Welling G.W. Kinetic analysis of synthetic analogues of linear-epitope peptides of glycoprotein D of herpes simplex virus type 1 by surface plasmon resonance. Eur. J. Biochem. 240:1996;209-214.
23. Fairley C.K., Begg N., Borrow R., Fox A.J., Jones D.M., Cartwright K. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J. Infect. Dis. 174:1996;1360-1363.
24. Parkhill J., Achtman M., James K.D., Bentley S.D., Churcher C., Klee S.R., Morelli G., Basham D., Brown D., Chillingworth T., Davies R.M., Davis P., Devlin K., Feltwell T., Hamlin N., Holroyd S., Jagels K., Leather S., Moule S., Mungall K., Quail M.A., Rajandream M.A., Rutherford K.M., Simmonds M., Skelton J., Whitehead S. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature. 404:2000;502-506.
25. Moran A.P., Prendergast M.M., Appelmelk B.J. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16:1996;105-115.
26. Rune Andersen S., Kolberg J., Hoiby E.A., Namork E., Caugant D.A., Oddvar Froholm L., Jantzen E., Bjune G. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development. Microb. Pathogen. 23:1997;139-155.
27. Scholten R.J., Kuipers B., Valkenburg H.A., Dankert J., Zollinger W.D., Poolman J.T. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J. Med. Microbiol. 41:1994;236-243.
28. Pinilla C., Appel J.R., Campbell G.D., Buencamino J., Benkirane N., Muller S., Greenspan N.S. All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library. J. Mol. Biol. 283:1998;1013-1025.
29. Moe G.R., Tan S., Granoff D.M. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol. Med. Microbiol. 26:1999;209-226.